The UK is reviewing diabetes medicine and weight-loss treatments Ozempic and Saxenda after some patients reported suicidal or self-harming thoughts. The Medicines and Healthcare products Regulatory ...
APPETITE curbing jabs Wegovy and Saxenda and diabetes drug Ozempic are set to undergo a safety review following reports of a possible link to thoughts of suicide and self-harm among users. The ...
Britain is the most obese nation in Europe, with more than 35 million people classed as either overweight or obese according to official figures - roughly half the population. A recent NHS report ...
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has urged healthcare professionals to ensure patients and the public are aware of the dangers of falsified Ozempic (semaglutide) and ...
If you are overweight or obese, you might be advised to lose weight by your GP, especially if it is causing you related health problems. You may also wish to lose weight for your own personal reasons.
LONDON, July 26 (Reuters) - Britain is reviewing a class of drugs used in a diabetes medicine and a weight-loss treatment sold by Novo Nordisk NOVOb.CO after some patients reported suicidal or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results